X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2709) 2709
Publication (143) 143
Book Review (22) 22
Book Chapter (15) 15
Magazine Article (8) 8
Newsletter (8) 8
Newspaper Article (2) 2
Conference Proceeding (1) 1
Data Set (1) 1
Dissertation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2240) 2240
asparaginase - therapeutic use (1380) 1380
male (1283) 1283
female (1257) 1257
child (1084) 1084
antineoplastic combined chemotherapy protocols - therapeutic use (950) 950
adolescent (902) 902
asparaginase - administration & dosage (853) 853
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (840) 840
child, preschool (759) 759
index medicus (669) 669
oncology (653) 653
hematology (634) 634
adult (608) 608
asparaginase - adverse effects (568) 568
antineoplastic agents - therapeutic use (507) 507
vincristine - administration & dosage (506) 506
animals (468) 468
asparaginase (463) 463
infant (463) 463
leukemia, lymphoid - drug therapy (455) 455
l-asparaginase (443) 443
middle aged (405) 405
vincristine - therapeutic use (393) 393
chemotherapy (372) 372
remission induction (369) 369
methotrexate - administration & dosage (364) 364
children (355) 355
treatment outcome (354) 354
cancer (322) 322
prednisone - administration & dosage (317) 317
prognosis (307) 307
cytarabine - administration & dosage (292) 292
prednisone - therapeutic use (291) 291
pediatrics (283) 283
acute lymphoblastic-leukemia (275) 275
leukemia - drug therapy (275) 275
therapy (274) 274
leukemia (270) 270
daunorubicin - administration & dosage (266) 266
acute lymphoblastic leukemia (256) 256
cyclophosphamide - administration & dosage (250) 250
antineoplastic combined chemotherapy protocols - adverse effects (247) 247
daunorubicin - therapeutic use (238) 238
aged (237) 237
methotrexate - therapeutic use (235) 235
cytarabine - therapeutic use (233) 233
mice (223) 223
cyclophosphamide - therapeutic use (218) 218
antineoplastic agents - adverse effects (190) 190
time factors (184) 184
doxorubicin - administration & dosage (178) 178
retrospective studies (176) 176
acute disease (175) 175
precursor cell lymphoblastic leukemia-lymphoma - mortality (175) 175
disease-free survival (173) 173
asparaginase - pharmacology (170) 170
combined modality therapy (170) 170
leukemia, myeloid, acute - drug therapy (169) 169
mercaptopurine - therapeutic use (164) 164
lymphoma, non-hodgkin - drug therapy (161) 161
drug therapy, combination (160) 160
mercaptopurine - administration & dosage (158) 158
childhood (155) 155
lymphoma - drug therapy (152) 152
recurrence (152) 152
escherichia coli - enzymology (146) 146
prednisolone - administration & dosage (142) 142
risk factors (142) 142
follow-up studies (141) 141
dexamethasone - administration & dosage (140) 140
remission, spontaneous (135) 135
young adult (134) 134
drug administration schedule (133) 133
antineoplastic agents - administration & dosage (130) 130
care and treatment (129) 129
survival rate (128) 128
acute lymphocytic leukemia (123) 123
antineoplastic combined chemotherapy protocols - administration & dosage (118) 118
neoplasms - drug therapy (117) 117
precursor cell lymphoblastic leukemia-lymphoma - blood (117) 117
research (115) 115
survival analysis (112) 112
precursor cell lymphoblastic leukemia-lymphoma - complications (111) 111
dogs (110) 110
pharmacology & pharmacy (110) 110
acute lymphocytic-leukemia (109) 109
asparaginase - metabolism (108) 108
age factors (106) 106
clinical trials as topic (106) 106
risk (106) 106
vincristine - adverse effects (105) 105
enzymes (102) 102
lymphomas (102) 102
prednisolone - therapeutic use (102) 102
precursor cell lymphoblastic leukemia-lymphoma - pathology (99) 99
etoposide - administration & dosage (93) 93
lymphoma (91) 91
doxorubicin - therapeutic use (90) 90
precursor cell lymphoblastic leukemia-lymphoma - genetics (90) 90
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2228) 2228
German (118) 118
Japanese (72) 72
French (68) 68
Polish (56) 56
Italian (51) 51
Russian (41) 41
Spanish (33) 33
Chinese (27) 27
Portuguese (7) 7
Czech (4) 4
Hungarian (4) 4
Romanian (4) 4
Dutch (3) 3
Norwegian (3) 3
Serbian (3) 3
Swedish (3) 3
Slovak (2) 2
Bosnian (1) 1
Bulgarian (1) 1
Croatian (1) 1
Danish (1) 1
Finnish (1) 1
Hebrew (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 05/2008, Volume 83, Issue 5, pp. 761 - 769
Nanotechnology is the understanding and control of matter generally in the 1–100 nm dimension range. The application of nanotechnology to medicine, known as... 
DIAGNOSIS | IN-VITRO | DRUG-DELIVERY | NANOMEDICINE | PHARMACOLOGY & PHARMACY | ALBUMIN | MAGNETIC NANOPARTICLES | VIVO ANTITUMOR-ACTIVITY | PHASE-I | LIPOSOMES | CANCER-THERAPY | Nanoparticles - chemistry | Nanoparticles - therapeutic use | Nanotechnology - methods | Drug Delivery Systems - methods | Humans
Journal Article
Journal Article
Blood, ISSN 0006-4971, 04/2017, Volume 129, Issue 17, pp. 2437 - 2442
Journal Article
Cancer Science, ISSN 1347-9032, 05/2008, Volume 99, Issue 5, pp. 1016 - 1020
Journal Article
Journal Article
Bioconjugate Chemistry, ISSN 1043-1802, 03/2018, Volume 29, Issue 3, pp. 649 - 656
Enzymes are attractive as immunotherapeutics because they can catalyze shifts in the local availability of immunostimulatory and immunosuppressive signals.... 
BIOCHEMISTRY & MOLECULAR BIOLOGY | BIOCHEMICAL RESEARCH METHODS | CHEMISTRY, ORGANIC | LYSOSOMAL STORAGE DISEASES | BLOOD-BRAIN-BARRIER | CHEMISTRY, MULTIDISCIPLINARY | ANTITUMOR IMMUNE-RESPONSES | ACUTE LYMPHOBLASTIC-LEUKEMIA | REPLACEMENT THERAPY | FUSION PROTEIN | ADENOSINE-DEAMINASE DEFICIENCY | POLYETHYLENE-GLYCOL | EXTRACELLULAR-SUPEROXIDE DISMUTASE | TARGETED DELIVERY | Glucosylceramidase - chemistry | alpha-Galactosidase - therapeutic use | Immunotherapy - methods | Humans | Anti-Inflammatory Agents - immunology | Antineoplastic Agents - therapeutic use | Asparaginase - chemistry | Gaucher Disease - therapy | Enzymes, Immobilized - immunology | Enzyme Therapy - methods | Immunoconjugates - immunology | alpha-Galactosidase - chemistry | Neoplasms - therapy | Lysosomal Storage Diseases - immunology | Anti-Inflammatory Agents - therapeutic use | Immunoconjugates - therapeutic use | Fabry Disease - immunology | alpha-Galactosidase - immunology | Asparaginase - therapeutic use | Enzymes, Immobilized - therapeutic use | Enzymes, Immobilized - chemistry | Biocatalysis | Lysosomal Storage Diseases - therapy | Antineoplastic Agents - immunology | Glucosylceramidase - immunology | Gaucher Disease - immunology | Glycosylation | Inflammation - immunology | Antineoplastic Agents - chemistry | Immunoconjugates - chemistry | Asparaginase - immunology | Inflammation - therapy | Animals | Anti-Inflammatory Agents - chemistry | Glucosylceramidase - therapeutic use | Neoplasms - immunology | Fabry Disease - therapy
Journal Article